Feb 28, 2017 13:02 pm UTC| Business
AUSTIN, Texas, Feb. 28, 2017 -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases...
Immunomedics to Present at Cowen and Company 37th Annual Health Care Conference
Feb 28, 2017 13:02 pm UTC| Business
MORRIS PLAINS, N.J., Feb. 28, 2017 -- Immunomedics, Inc., (NASDAQ:IMMU) (“Immunomedics” or “the Company”) today announced that the Company will present at Cowen and Company37th AnnualHealth Care Conference on Tuesday,...
Immunomedics to Present at Cowen and Company 37th Annual Health Care Conference
Feb 28, 2017 13:02 pm UTC| Business
MORRIS PLAINS, N.J., Feb. 28, 2017 -- Immunomedics, Inc., (NASDAQ:IMMU) (“Immunomedics” or “the Company”) today announced that the Company will present at Cowen and Company37th AnnualHealth Care Conference on Tuesday,...
Ekso Bionics® EksoZeroG Technology Named to Industry Hot List
Feb 28, 2017 13:02 pm UTC| Business
RICHMOND, Calif., Feb. 28, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, announced that its EksoZeroG industrial solution has been named to the industry recognized Hot List 2017....
Ekso Bionics® EksoZeroG Technology Named to Industry Hot List
Feb 28, 2017 13:02 pm UTC| Business
RICHMOND, Calif., Feb. 28, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, announced that its EksoZeroG industrial solution has been named to the industry recognized Hot List 2017....
3D Systems Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 28, 2017 13:02 pm UTC| Business
Revenue of $165.9 million in the fourth quarter with continued strong gross profit marginGAAP earnings of $0.05 per share and non-GAAP earnings of $0.15 per share in the fourth quarterGenerated $18.7 million of cash from...
3D Systems Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 28, 2017 13:02 pm UTC| Business
Revenue of $165.9 million in the fourth quarter with continued strong gross profit marginGAAP earnings of $0.05 per share and non-GAAP earnings of $0.15 per share in the fourth quarterGenerated $18.7 million of cash from...